ArrayGenomics is leading the revolution in bladder cancer surveillance ArrayGenomics offers a robust, highly sensitive, non-invasive, molecular monitoring test using micro-array CGH technology. For those affected with BC, cystoscopy is often seen as the gold standard for monitoring of BC. Our BCA-1 test has shown to be more sensitive and with a high NPV (Negative Predictive Value). We offer clinicians and patients the safety of monitoring the evolution of your conditions without the pain or the stress that comes with cystoscopy. The future of bladder cancer surveillance is already here. Come and be part of the solution